pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,885 catalysts · 4,876 phase readout · 2,346 8k filing · 286 earnings · 271 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 8 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: patent expiry×type: phase readout×clear all
type
  • phase readout4,876
  • 8k filing2,346
  • earnings286
  • pdufa271
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area
    • Infectious Disease7
    • Dermatology1
    • Oncology1

    Date TBD

    50
    ›RECRUITINGphase readoutNCT06971952: Tuberculosis in Rural and Malnourished Populations

    Sponsor: University of Virginia. Phase: NA. Conditions: Tuberculosis (TB), Undernutrition

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04522947: Modifiable Predictors of Neural Vulnerabilities for Obesity

    Sponsor: University of Nebraska Lincoln. Phase: NA. Conditions: Obesity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06426147: L-citrulline to Improve Adverse Outcomes in Admitted Children (EChiLiBRiST, Clinical Trial 2, Inpatients)

    Sponsor: Barcelona Institute for Global Health. Phase: NA. Conditions: Infectious Disease, Infections, Child, Only

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07345247: RAdiation SEgmentectomy With REsin Microspheres (RASEREM) Study

    Sponsor: Ankara University. Phase: . Conditions: Liver Cancer, Adult

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06532747: Redefining BMI: The Body, Mind, and Inflammation Trial

    Sponsor: Virginia Commonwealth University. Phase: NA. Conditions: Obesity, Adiposity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03520647: Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis

    Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: PHASE2. Conditions: Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06645847: Targeting Aging With a Ketone Ester for Function in Frailty

    Sponsor: Buck Institute for Research on Aging. Phase: NA. Conditions: Frail Elderly, Aging, Immune Function, Muscle Function

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07031947: The Effect of Core Stabilization Exercises Applied With Virtual Reality-Based Telerehabilitation in the Treatment of Chronic Low Back Pain

    Sponsor: Istanbul University. Phase: NA. Conditions: Low Back Pain, Low Back Pain, Mechanical, Low Back Pain and Core Muscle, Core Stabilization Exercise Therapy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07459647: A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

    Sponsor: MapLight Therapeutics. Phase: PHASE2. Conditions: Schizophrenia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07245849: Pericardial Imaging Study

    Sponsor: Ottawa Heart Institute Research Corporation. Phase: PHASE3. Conditions: Pericarditis

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04615949: Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors

    Sponsor: Cardiol Therapeutics Inc.. Phase: PHASE2. Conditions: COVID-19, Cardiovascular Diseases, Cardiovascular Risk Factor

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07139158: Muscle Oxygenation in Patellofemoral Pain

    Sponsor: Ankara Medipol University. Phase: . Conditions: Patellofemoral Pain, PFP

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06008158: Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation for Improved Breast Appearance in Pts w/Low Risk, Hormone Responsive Brst Ca

    Sponsor: City of Hope Medical Center. Phase: PHASE2. Conditions: Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Estrogen Receptor-Positive Breast Carcinoma, HER2-Negative Breast Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06948058: Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy

    Sponsor: Brown University. Phase: NA. Conditions: Smoking Cessation, Obesity and Obesity-related Medical Conditions

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04791748: Virtual Reality in Children With and Without Vestibular Deficits

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Vestibular Diseases

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07543848: A Prospective, Multicenter, Single-Arm Phase II Exploratory Study of Serplulimab Combined With Oncolytic Virus H101, Short-Course Radiotherapy, and XELOX Chemotherapy as Total Neoadjuvant Treatment for Locally Advanced (cT1-3N0M0) Rectal Cancer

    Sponsor: Chongqing University Cancer Hospital. Phase: PHASE2. Conditions: Rectal Neoplasms, Rectal Adenocarcinoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07409948: Multicomponent Care for Aromatase Inhibitor-Related Musculoskeletal Symptoms

    Sponsor: Addis Ababa University. Phase: NA. Conditions: Breast Neoplasms, Musculoskeletal Pain, Arthralgia, Musculoskeletal Diseases, Pain, Fatigue Syndrome, Chronic

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04199026: Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

    Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Metastatic Sarcoma, Recurrent Sarcoma, Resectable Sarcoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06688526: Auditory Stimulation Effect on Brain Oscillations and Sleep Dependent Learning

    Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Healthy Control

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06311578: A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors

    Sponsor: Johnson & Johnson Enterprise Innovation Inc.. Phase: PHASE1. Conditions: Neoplasms

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03807778: A Study of Mobocertinib in Japanese Adults With Non-Small Cell Lung Cancer

    Sponsor: Takeda. Phase: PHASE1. Conditions: Non-Small Cell Lung Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07356778: A Study of Sotatercept for Patients With Eisenmenger Syndrome or Unrepaired Shunt-Associated Pulmonary Arterial Hypertension Resistant to Vasodilator Therapy

    Sponsor: Kazuya Hosokawa. Phase: PHASE4. Conditions: Eisenmenger Syndrome, Pulmonary Arterial Hypertension of Congenital Heart Disease

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03946878: Venetoclax and Acalabrutinib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Blastoid Variant Mantle Cell Lymphoma, CCND1 Protein Overexpression, CD20 Positive, CD5 Positive, FCER2 Negative, Pleomorphic Variant Mantle Cell Lymphoma, Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma, t(11;14)(q13;q32)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07588178: Metabolomics and Biomarker Research on the Mechanism of Preoperative Sleep Disorders Affecting Postoperative Outcomes in Cardiac Surgery Patients

    Sponsor: Yan Fuxia. Phase: . Conditions: Delirium - Postoperative, Sleep Problems

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07028385: Safety and Impact of Baricitinib on Cell Surivival Pathways, HIV-1 Reservoir and Inflamation in People With HIV-1

    Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia. Phase: PHASE2. Conditions: HIV

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT03588585: Tension Versus no Tension With Foley Bulb Induction

    Sponsor: Hawaii Pacific Health. Phase: NA. Conditions: Induction of Labor Affected Fetus / Newborn

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07434843: PH 2 Pemigatinib in SDH-deficient GIST

    Sponsor: Dana-Farber Cancer Institute. Phase: PHASE2. Conditions: SDH Gene Mutation, Gastrointestinal Stromal Tumor

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05565443: MR-guided Focused Ultrasound Plus GCase

    Sponsor: InSightec. Phase: NA. Conditions: Parkinsons Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07265115: Preventive Nutritional Supplements for Preclinical Pathologies

    Sponsor: Centro de Edafología y Biología Aplicada del Segura. Phase: NA. Conditions: Prediabetes

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06512935: Ventilator Pressure and Optimization of Compliance and Hemodynamics

    Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Bronchopulmonary Dysplasia, Pulmonary Hypertension Due to Lung Diseases and Hypoxia, Extreme Prematurity, Ventilator Lung; Newborn, Ventilation Perfusion Mismatch

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04211935: Identification of Best Postoperative Analgesia Method Following a Minimally Invasive Repair of Pectus Excavatum

    Sponsor: University of Colorado, Denver. Phase: NA. Conditions: Pectus Excavatum, Pain, Postoperative

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07552025: Detection of Respiratory Events Using Acoustic Monitoring in Extremely Preterm Infants

    Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre. Phase: . Conditions: Apnea of Prematurity, Preterm Infant, Periodic Breathing, Hypopnea

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07584525: Dexamethasone in Tick-borne Encephalitis

    Sponsor: University Medical Centre Ljubljana. Phase: PHASE3. Conditions: Tick-Borne Encephalitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05849025: A Study of Invasive Hemodynamic for MACHD Registry

    Sponsor: Mayo Clinic. Phase: . Conditions: Healthy, Congenital Heart Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07525076: Implementation of an Opt-Out Testing and Rapid Diagnostic Strategy for Syphilis and HIV in Pregnant Patients Presenting to the Emergency Department

    Sponsor: The University of Texas Health Science Center, Houston. Phase: NA. Conditions: HIV Infections, Syphilis Infection

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04397276: A Study of JNJ-70218902 in Participants With Advanced Stage Solid Tumors

    Sponsor: Janssen Research & Development, LLC. Phase: PHASE1. Conditions: Neoplasms

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02824276: Sensory Effects of Oral Opioid Treatment in Patients With Chronic Low Back Pain

    Sponsor: Brigham and Women's Hospital. Phase: PHASE1. Conditions: Low Back Pain

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02592317: A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer

    Sponsor: Aragon Pharmaceuticals, Inc.. Phase: PHASE1. Conditions: Prostatic Neoplasms, Castration-Resistant

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07585240: Effect of Warm Footbath Combined With Relaxation Exercise on Pain and Anxiety During Chest Tube Removal After Cardiac Surgery

    Sponsor: Igdir University. Phase: NA. Conditions: Chest Tube Removal

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07441668: Comfort Intervention in PICU Children

    Sponsor: Ankara Yildirim Beyazıt University. Phase: NA. Conditions: Pediatric Intensive Care Unit, Comfort, Anxiety in Children, Fear, Sleep

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05876468: Effects of Continuous Anterior Chest Compression

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Evaluable

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT01750619: Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions

    Sponsor: California Pacific Medical Center Research Institute. Phase: . Conditions: Gastrointestinal Neoplasms, Benign Neoplasm of Intestinal Tract

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06639919: Biochemical and Histological Changes in Pregnant Women With Preterm Premature Rupture of Membrane

    Sponsor: Celal Bayar University. Phase: . Conditions: Preterm Premature Rupture of Membrane, Placenta Diseases

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06697730: Study of the Incidence and Prognosis of Intrahospital Acute Kidney Injury

    Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico. Phase: . Conditions: Acute Kidney Injury

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07519330: Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic Hepatitis B Virus Infection

    Sponsor: Huahui Health. Phase: PHASE2. Conditions: Chronic Hepatitis B Virus Infection

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07571928: A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive Azoospermia

    Sponsor: Martin Blomberg Jensen. Phase: PHASE1. Conditions: Infertility Due to Azoospermia, Infertility, Male

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05845528: Impact of Susceptibility to Placebo on the Effect of Transcranial Direct Current Stimulation (tDCS) in Fibromyalgia

    Sponsor: Hospital de Clinicas de Porto Alegre. Phase: NA. Conditions: Fibromyalgia

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT00923065: Data Collection, Clinical Care and Interventions in CCR, NCI

    Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Neoplasms, Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06556667: MAX - SHOCK Clinical Trial

    Sponsor: Ottawa Heart Institute Research Corporation. Phase: NA. Conditions: Cardioversion, Atrial Fibrillation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05105100: Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma

    Sponsor: University of California, San Francisco. Phase: . Conditions: Melanoma, Advanced Melanoma

    full page →ctgov ↗
    ← prev
    page 33 of 98
    next →